The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 1,121 | 9,245 | SH | SOLE | 9,245 | 0 | 0 | ||
ANHEUSER BUSCH INBEV SA/NV | SPONSORED ADR | 03524A108 | 12,041 | 109,700 | SH | SOLE | 109,700 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 1,898 | 21,624 | SH | SOLE | 21,624 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 1,758 | 14,131 | SH | SOLE | 14,131 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 2,030 | 15,188 | SH | SOLE | 15,188 | 0 | 0 | ||
ISHARES | MSCI BRZ CAP ETF | 464286400 | 375 | 10,000 | SH | Put | SOLE | 10,000 | 0 | 0 | |
ISHARES | MSCI BRZ CAP ETF | 464286400 | 3,746 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
KRAFT HEINZ CO | COM | 500754106 | 46,030 | 506,888 | SH | SOLE | 506,888 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 670 | 7,969 | SH | SOLE | 7,969 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 299 | 6,903 | SH | SOLE | 6,903 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 457 | 1,179 | SH | SOLE | 1,179 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 404 | 6,433 | SH | SOLE | 6,433 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 47,148 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
TESARO INC | COM | 881569107 | 440 | 2,860 | SH | SOLE | 2,860 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 1,603 | 9,772 | SH | SOLE | 9,772 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 365 | 3,339 | SH | SOLE | 3,339 | 0 | 0 |